Johnson & Johnson (JNJ)Officer sold ~$10M

~$10M

Approx. value · 56K sh @ $177.81

178K

Holds after · shares reported

Traded

Sep 4, 2025

Filed

Sep 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 15, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Oct 29, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
4. Mar 19, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
5. Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
6. Jun 16, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
7. Jun 17, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
8. Jun 24, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
9. Jul 17, 2025InsiderOfficer sold ~$3.13M of JNJ shares in the open market
10. Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
11. Aug 4, 2025Congress · 1 personMembers of Congress: 2 purchases
12. Aug 14, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
13. Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
14. Aug 19, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
15. Aug 22, 2025InsiderCEO sold ~$22.5M of JNJ shares in the open market
16. Sep 4, 2025 · this disclosureInsider · 4 days before an 8-KOfficer sold ~$10M of JNJ shares in the open market

What came next

1. Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, Johnson & Johnson (the Company) announced that John Morikis was elected to the Board of Directors. The Board has determined that Mr. Morikis satisfies the applicable independence requirements of the NYSE Listed Company Manual.”
2. Sep 23, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
3. Oct 1, 2025FDARecall: Automated Impella Controller (AIC), used for left heart support blood pump, labeled as the following with corresponding Product Codes: 1. Impella Controller, P…
4. Oct 8, 2025FDAFDA device clearance: 14Fr Low Profile Introducer Kit
5. Oct 9, 2025Federal contract · $19K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $19K obligated to date
6. Oct 10, 2025Congress · 1 personMembers of Congress: 2 sales
7. Oct 14, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
8. Oct 16, 2025Federal contract · $384K obligatedDepartment of Defense awarded Johnson & Johnson: $384K obligated to date
9. Oct 17, 2025InsiderOfficer sold ~$4.19M of JNJ shares in the open market
10. Oct 18, 2025FDARecall: MONARCH Bronchoscope. Model Number: MBR-000211-B
11. Oct 21, 2025FDAFDA device clearance: TriALTIS™ Spine System
12. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
13. Oct 31, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
14. Nov 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
15. Nov 6, 2025FDAFDA drug approval: Darzalex Faspro
16. Nov 6, 2025Insider10% owner sold ~$534K of JNJ shares in the open market
17. Nov 7, 2025Insider10% owner sold ~$2K of JNJ shares in the open market
18. Nov 12, 2025FDAFDA device clearance: Synthes Patient Specific Implants
19. Nov 12, 2025FDAFDA device clearance: PDS™ Plus Antibacterial (Polydioxanone) Sterile Synthetic Absorbable Surgical Suture
20. Nov 12, 2025Insider10% owner sold ~$10K of JNJ shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Jennifer L Taubert, EVP, WWC. Innovative Medicine

• SEC Form 4 at Johnson & Johnson (JNJ)Aug 18, 2026

The full history of Jennifer L Taubert, EVP, WWC. Innovative Medicine is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026
• Senate eFD periodic transaction reportSep 11, 2026

Everything OQRO holds on this company is on its JNJ page.